Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
AstraZeneca
AstraZeneca
AstraZeneca
Astellas Pharma Inc
UNICANCER
UNICANCER
Leap Therapeutics, Inc.
Servicio de Salud Metropolitano Sur Oriente
Imugene Limited
Eurofarma Laboratorios S.A.
University Hospital Schleswig-Holstein
Sumitomo Pharma America, Inc.
Chinese University of Hong Kong
Medical College of Wisconsin
UNICANCER
M.D. Anderson Cancer Center
University of Florida
Cedars-Sinai Medical Center
Memorial Sloan Kettering Cancer Center
Abramson Cancer Center at Penn Medicine
University of California, San Francisco
H. Lee Moffitt Cancer Center and Research Institute
McGill University
Sixth Affiliated Hospital, Sun Yat-sen University
Stanford University
H. Lee Moffitt Cancer Center and Research Institute
Chiron Corporation